Anbio Biotechnology Class A Share Price

Anbio Biotechnology Class A Share Price

NASDAQ: NNNN
$3.48
-$0.29 (-7.81%) Last updated on 31 Oct, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Anbio Biotechnology Class A Stock Performance

Open
$3.63
Prev. Close
$3.77
Circuit Range
N/A
Day Range
$3.49 - $3.65
Year Range
$3.11 - $42.83
Volume
397
Average Traded
$3.59

Anbio Biotechnology Class A Share Price Today

As of 31 October 2026, Anbio Biotechnology Class A's share price is $3.48. The stock opened at $3.63, compared to its previous close of $3.77. During today's trading session, Anbio Biotechnology Class A's share price traded between $3.49 and $3.65, with an average price of $3.57. Over the past 52 weeks, the stock has recorded a high of $42.83 and a low of $3.11. In terms of performance, Anbio Biotechnology Class A's share price has declined by 87.57% over the last six months and is down 83.68% on a year-on-year basis.

Anbio Biotechnology Class A Share Price Chart

Line chart of the Anbio Biotechnology Class A price trend over the selected period. The price fell overall, ranging from 3.48 to 3.73, ending at 3.48.
$3.49$3.65
L
Show Current Price
H

Anbio Biotechnology Class A Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$8.65B
Return On Equity (TTM)
N/A
Profit Margin
73.99%
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Anbio Biotechnology Class A Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$8.65
Net Profit$6.40
Net Profit Margin73.99%
Income ChangeN/A

About Anbio Biotechnology Class A

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Anbio Biotechnology Class A Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$6.27
$3.49
-43.80%
Sep 2026
$7.12
$6.21
-21.19%
Aug 2026
$11.75
$7.88
-19.18%
Jul 2026
$12.62
$9.75
-30.85%
Jun 2026
$32.02
$14.10
-55.76%
May 2026
$31.57
$31.88
+13.84%
Apr 2026
$26.45
$28.00
+8.74%
Mar 2026
$23.70
$25.75
-13.46%
Feb 2026
$21.16
$29.75
+45.11%
Jan 2026
$33.44
$20.50
-30.82%
Dec 2025
$36.90
$29.64
+110.81%
Nov 2025
$16.07
$14.06
-34.08%

NNNN Share Price FAQs